These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 35256883)

  • 21. COVID-19 Vaccination and Diabetes Mellitus: How Much Has It Made a Difference to Outcomes Following Confirmed COVID-19 Infection?
    Heald AH; Jenkins DA; Williams R; Mudaliar RN; Naseem A; Davies KAB; Gibson JM; Peng Y; Ollier W
    Diabetes Ther; 2023 Jan; 14(1):193-204. PubMed ID: 36478309
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study.
    Petrilli CM; Jones SA; Yang J; Rajagopalan H; O'Donnell L; Chernyak Y; Tobin KA; Cerfolio RJ; Francois F; Horwitz LI
    BMJ; 2020 May; 369():m1966. PubMed ID: 32444366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Addition of Basal Insulin to Oral Antidiabetic Agents in Patients with Inadequately Controlled Type 2 Diabetes Leads to Improved HbA1c Levels: Metabolic Control, Frequency of Hypoglycemia, and Insulin Titration Analysis as Results of a Prospective Observational Study (BALI Study).
    Brož J; Janíčková Ždárská D; Štěpánová R; Kvapil M
    Diabetes Ther; 2019 Apr; 10(2):663-672. PubMed ID: 30788806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and feasibility of basal-bolus insulin regimens and a discharge-strategy in hospitalised patients with type 2 diabetes--the HOSMIDIA study.
    Pérez A; Reales P; Barahona MJ; Romero MG; Miñambres I;
    Int J Clin Pract; 2014 Oct; 68(10):1264-71. PubMed ID: 25269951
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding 30-day re-admission after hospitalisation of older patients for diabetes: identifying those at greatest risk.
    Caughey GE; Pratt NL; Barratt JD; Shakib S; Kemp-Casey AR; Roughead EE
    Med J Aust; 2017 Mar; 206(4):170-175. PubMed ID: 28253467
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 infection in pregnancy in Denmark-characteristics and outcomes after confirmed infection in pregnancy: A nationwide, prospective, population-based cohort study.
    Aabakke AJM; Krebs L; Petersen TG; Kjeldsen FS; Corn G; Wøjdemann K; Ibsen MH; Jonsdottir F; Rønneberg E; Andersen CS; Sundtoft I; Clausen T; Milbak J; Burmester L; Lindved B; Thorsen-Meyer A; Khalil MR; Henriksen B; Jønsson L; Andersen LLT; Karlsen KK; Pedersen ML; Klemmensen Å; Vestgaard M; Thisted D; Tatla MK; Andersen LS; Brülle AL; Gulbech A; Andersson CB; Farlie R; Hansen L; Hvidman L; Sørensen AN; Rathcke SL; Rubin KH; Petersen LK; Jørgensen JS; Stokholm L; Bliddal M
    Acta Obstet Gynecol Scand; 2021 Nov; 100(11):2097-2110. PubMed ID: 34467518
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls.
    Goyal A; Gupta Y; Kalaivani M; Praveen PA; Ambekar S; Tandon N
    Endocr Pract; 2022 Feb; 28(2):191-198. PubMed ID: 34920109
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of Maternal Perinatal SARS-CoV-2 Infection With Neonatal Outcomes During the COVID-19 Pandemic in Massachusetts.
    Angelidou A; Sullivan K; Melvin PR; Shui JE; Goldfarb IT; Bartolome R; Chaudhary N; Vaidya R; Culic I; Singh R; Yanni D; Patrizi S; Hudak ML; Parker MG; Belfort MB
    JAMA Netw Open; 2021 Apr; 4(4):e217523. PubMed ID: 33890989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Severe obesity in a specialist type 2 diabetes outpatient clinic: an Australian retrospective cohort study.
    Thakur A; Sharma D; Gupta B; Kramadhari N; Rajagopal R; Simmons D; Piya MK
    BMC Endocr Disord; 2021 Mar; 21(1):55. PubMed ID: 33757476
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Increased risk of hospitalisation and intensive care admission associated with reported cases of SARS-CoV-2 variants B.1.1.7 and B.1.351 in Norway, December 2020 -May 2021.
    Veneti L; Seppälä E; Larsdatter Storm M; Valcarcel Salamanca B; Alnes Buanes E; Aasand N; Naseer U; Bragstad K; Hungnes O; Bøås H; Kvåle R; Golestani K; Feruglio S; Vold L; Nygård K; Whittaker R
    PLoS One; 2021; 16(10):e0258513. PubMed ID: 34634066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged Oxygen Therapy Post COVID-19 Infection: Factors Leading to the Risk of Poor Outcome.
    Ray A; Chaudhry R; Rai S; Mitra S; Pradhan S; Sunder A; Nag DS
    Cureus; 2021 Feb; 13(2):e13357. PubMed ID: 33633916
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study.
    Daugherty SE; Guo Y; Heath K; Dasmariñas MC; Jubilo KG; Samranvedhya J; Lipsitch M; Cohen K
    BMJ; 2021 May; 373():n1098. PubMed ID: 34011492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of maternal SARS-CoV-2 infection timing on birth outcomes: a retrospective multicentre cohort study.
    Piekos SN; Roper RT; Hwang YM; Sorensen T; Price ND; Hood L; Hadlock JJ
    Lancet Digit Health; 2022 Feb; 4(2):e95-e104. PubMed ID: 35034863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus.
    Jing Liang J; Liu J; Chen Y; Ye B; Li N; Wang X; Tang M; Shao J
    Diabetes Res Clin Pract; 2020 Sep; 167():108351. PubMed ID: 32711001
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of Life 6 Months after COVID-19 Hospitalisation: A Single-Centre Polish Registry.
    Koźlik M; Kaźmierski M; Kaźmierski W; Lis P; Lis A; Łowicka W; Chamera M; Romanowska B; Kufel J; Cebula M; Jędrzejek M
    J Clin Med; 2023 Aug; 12(16):. PubMed ID: 37629369
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin Requirements During Severe COVID-19 Were Relatively Low in Japanese Patients With Type 2 Diabetes: Two Case Reports.
    Yamamoto J; Takahashi H; Saito T; Yamamoto Y; Takahashi K; Itakura K; Kobayashi M; Igusa R; Kobayashi T; Ichinose M; Usui M
    Cureus; 2023 Oct; 15(10):e47654. PubMed ID: 38022370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe hyperglycemia and insulin resistance in patients with SARS-CoV-2 infection: a report of two cases.
    Affinati AH; Wallia A; Gianchandani RY
    Clin Diabetes Endocrinol; 2021 May; 7(1):8. PubMed ID: 33992101
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A case of new-onset Fulminant type 1 diabetes after secondary SARS-CoV-2 infection.
    Wang J; Huang Y; Tao F
    Heliyon; 2024 May; 10(9):e30750. PubMed ID: 38756607
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recent Progress in the Diagnosis and Management of Type 2 Diabetes Mellitus in the Era of COVID-19 and Single Cell Multi-Omics Technologies.
    Kupai K; Várkonyi T; Török S; Gáti V; Czimmerer Z; Puskás LG; Szebeni GJ
    Life (Basel); 2022 Aug; 12(8):. PubMed ID: 36013384
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.